Selective depletion of a minor subpopulation of B-chronic lymphocytic leukemia cells is followed by a delayed but progressive loss of bulk tumor cells and disease regression
Kadia TM, Js C, Konopleva M, Borthakur G, Pemmaraju N, Daver N, Montalban-Bravo G, Issa G, Naqvi K, Short N, Dinardo C, Bhalla K, Jabbour E, Takahashi K, Sasaki K, Kornblau S, Malla R, Pierce S, Estrov Z, Andreeff M , Garcia-Manero G, Ravandi F, and Kantarjian H
Today @Roche announced positive results from our Phase I clinical trial of CT-388, a dual GLP-1/GIP receptor agonist being developed for the treatment of #obesity and type 2 #diabetes
L carnitine (kyu aur kaise) | What is L Carnitine and its 5 benefits for men | Dr
It remains a research compound that some clinics and individuals have begun using despite the lack of regulatory approval
They highlight the importance of individualized care, the potential need for adjustments in treatment plans, and the value of patient education and support networks